Suppr超能文献

多中心欧洲艾滋病毒阳性患者神经认知障碍及相关因素的流行状况研究。

Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.

机构信息

Research Department of Infection and Population Health, Mortimer Market Centre, University College London, Capper Street, London, WC1E 6JB, UK.

Department of Psychology, King's College London, London, UK.

出版信息

AIDS Behav. 2018 May;22(5):1573-1583. doi: 10.1007/s10461-017-1683-z.

Abstract

We conducted a cross-sectional study in 448 HIV positive patients attending five European outpatient clinics to determine prevalence of and factors associated with neurocognitive impairment (NCI) using computerized and pen-and-paper neuropsychological tests. NCI was defined as a normalized Z score ≤-1 in at least 2 out of 5 cognitive domains. Participants' mean age was 45.8 years; 84% male; 87% white; 56% university educated; median CD4 count 550 cells/mm; 89% on antiretroviral therapy. 156 (35%) participants had NCI, among whom 26 (17%; 5.8% overall) reported a decline in activities of daily living. Prevalence of NCI was lower in those always able to afford basic needs (adjusted prevalence ratio [aPR] 0.71, 95% confidence interval [CI] 0.54-0.94) or with a university education (aPR 0.72, 95% CI 0.54-0.97) and higher in those with severe depressive symptoms (aPR 1.53, 95% CI 1.09-2.14) or a significant comorbid condition (aPR 1.40, 95% CI 1.03-1.90).

摘要

我们在欧洲的五家门诊诊所对 448 名 HIV 阳性患者进行了一项横断面研究,旨在使用计算机化和纸笔神经心理学测试来确定神经认知障碍(NCI)的患病率以及与之相关的因素。NCI 定义为至少 5 个认知域中的 2 个的标准化 Z 分数≤-1。参与者的平均年龄为 45.8 岁;84%为男性;87%为白人;56%受过大学教育;中位数 CD4 计数为 550 个细胞/mm;89%接受抗逆转录病毒治疗。156 名(35%)参与者存在 NCI,其中 26 名(17%;总体 5.8%)报告日常生活活动能力下降。在那些始终能够负担基本需求的参与者(调整后的患病率比[aPR]0.71,95%置信区间[CI]0.54-0.94)或具有大学教育背景的参与者(aPR 0.72,95%CI 0.54-0.97)中,NCI 的患病率较低,而在那些存在严重抑郁症状(aPR 1.53,95%CI 1.09-2.14)或存在显著合并症的参与者(aPR 1.40,95%CI 1.03-1.90)中,NCI 的患病率较高。

相似文献

2
Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
AIDS Patient Care STDS. 2018 Jan;32(1):1-8. doi: 10.1089/apc.2017.0202.
3
Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
J Int AIDS Soc. 2010 Apr 20;13:15. doi: 10.1186/1758-2652-13-15.
4
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.
Neurology. 2013 Jan 22;80(4):371-9. doi: 10.1212/WNL.0b013e31827f0776. Epub 2013 Jan 9.
5
Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
J Clin Exp Neuropsychol. 2017 Oct;39(8):753-767. doi: 10.1080/13803395.2016.1263282. Epub 2017 Jan 4.
6
Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.
Int J STD AIDS. 2013 Mar;24(3):217-9. doi: 10.1177/0956462412472452. Epub 2013 May 6.
9
Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
J Neuroimmune Pharmacol. 2017 Dec;12(4):661-669. doi: 10.1007/s11481-017-9748-3. Epub 2017 May 3.

引用本文的文献

3
Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV.
AIDS. 2025 Mar 15;39(4):393-402. doi: 10.1097/QAD.0000000000004080. Epub 2024 Dec 19.
7
Dementia, infections and vaccines: 30 years of controversy.
Aging Clin Exp Res. 2023 Jun;35(6):1145-1160. doi: 10.1007/s40520-023-02409-8. Epub 2023 May 9.
9
Is International HIV Dementia Scale good enough to diagnose HIV-associated neurocognitive disorders?
J Family Med Prim Care. 2022 Sep;11(9):5060-5064. doi: 10.4103/jfmpc.jfmpc_356_21. Epub 2022 Oct 14.
10
Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder.
J Neurovirol. 2022 Dec;28(4-6):537-551. doi: 10.1007/s13365-022-01093-0. Epub 2022 Sep 1.

本文引用的文献

2
Cognitive function in women with HIV: findings from the Women's Interagency HIV Study.
Neurology. 2015 Jan 20;84(3):231-40. doi: 10.1212/WNL.0000000000001151. Epub 2014 Dec 24.
3
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.
Clin Infect Dis. 2015 Feb 1;60(3):473-80. doi: 10.1093/cid/ciu862. Epub 2014 Oct 31.
5
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.
Neurology. 2014 Jun 10;82(23):2055-62. doi: 10.1212/WNL.0000000000000492. Epub 2014 May 9.
6
Measuring the mind: assessing cognitive change in clinical drug trials.
Expert Rev Clin Pharmacol. 2008 Jul;1(4):471-3. doi: 10.1586/17512433.1.4.471.
7
Neurocognitive function in HIV infected patients on antiretroviral therapy.
PLoS One. 2013 Apr 30;8(4):e61949. doi: 10.1371/journal.pone.0061949. Print 2013.
8
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.
Neurology. 2013 Jan 22;80(4):371-9. doi: 10.1212/WNL.0b013e31827f0776. Epub 2013 Jan 9.
9
Cognitive disorders in HIV-infected patients: are they HIV-related?
AIDS. 2013 Jan 28;27(3):391-400. doi: 10.1097/QAD.0b013e32835b1019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验